Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P DOMINGO

Showing results (261-270 of 276) with videos related to

Pageof 28
Sort By:
Current HIV Research|February 15, 2019
Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR StudyD Podzamczer, N Rozas, P Domingo, et al.
The Journal of Antimicrobial Chemotherapy|May 23, 2018
Lipid changes and tolerability in a cohort of adult HIV-infected patients who switched to rilpivirine/emtricitabine/tenofovir due to intolerance to previous combination ART: the PRO-STR studyA Ocampo, P Domingo, P Fernández, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 18, 2015
HIV/antiretroviral therapy-related lipodystrophy syndrome (HALS) is associated with higher RBP4 and lower omentin in plasmaJ Peraire, M López-Dupla, V Alba, et al.
Antiviral Therapy|July 19, 2005
Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-upE Negredo, R Paredes, A Bonjoch, et al.
HIV Medicine|September 30, 2009
The relationship between antiretroviral prescription patterns and treatment guidelines in treatment-naïve HIV-1-infected patientsI Suarez-Lozano, P Viciana, J-R Lacalle, et al.
HIV Medicine|February 9, 2019
Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDAS Amele, L Peters, M Sluzhynska, et al.
The Journal of Hospital Infection|November 19, 2018
Staphylococcus aureus meningitis in adults: A comparative cohort study of infections caused by meticillin-resistant and meticillin-susceptible strainsV Pintado, R Pazos, M E Jiménez-Mejías, et al.
The Journal of Antimicrobial Chemotherapy|September 15, 2020
Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotypingM Casadellà, J R Santos, M Noguera-Julian, et al.
Nutricion Hospitalaria|April 10, 2007
Recommendations from SPNS/GEAM/SENBA/SENPE/AEDN/SEDCA/GESIDA on nutrition in the HIV-infected patientR Polo, C Gómez-Candela, C Miralles, et al.
HIV Medicine|August 2, 2016
Very low level viraemia and risk of virological failure in treated HIV-1-infected patientsR Teira, F Vidal, P Muñoz-Sánchez, et al.
Pageof 28

Showing results (261-270 of 276) with videos related to

Sort By:
Pageof 28
Current HIV Research|February 15, 2019
Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR StudyD Podzamczer, N Rozas, P Domingo, et al.
The Journal of Antimicrobial Chemotherapy|May 23, 2018
Lipid changes and tolerability in a cohort of adult HIV-infected patients who switched to rilpivirine/emtricitabine/tenofovir due to intolerance to previous combination ART: the PRO-STR studyA Ocampo, P Domingo, P Fernández, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 18, 2015
HIV/antiretroviral therapy-related lipodystrophy syndrome (HALS) is associated with higher RBP4 and lower omentin in plasmaJ Peraire, M López-Dupla, V Alba, et al.
Antiviral Therapy|July 19, 2005
Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-upE Negredo, R Paredes, A Bonjoch, et al.
HIV Medicine|September 30, 2009
The relationship between antiretroviral prescription patterns and treatment guidelines in treatment-naïve HIV-1-infected patientsI Suarez-Lozano, P Viciana, J-R Lacalle, et al.
HIV Medicine|February 9, 2019
Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDAS Amele, L Peters, M Sluzhynska, et al.
The Journal of Hospital Infection|November 19, 2018
Staphylococcus aureus meningitis in adults: A comparative cohort study of infections caused by meticillin-resistant and meticillin-susceptible strainsV Pintado, R Pazos, M E Jiménez-Mejías, et al.
The Journal of Antimicrobial Chemotherapy|September 15, 2020
Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotypingM Casadellà, J R Santos, M Noguera-Julian, et al.
Nutricion Hospitalaria|April 10, 2007
Recommendations from SPNS/GEAM/SENBA/SENPE/AEDN/SEDCA/GESIDA on nutrition in the HIV-infected patientR Polo, C Gómez-Candela, C Miralles, et al.
HIV Medicine|August 2, 2016
Very low level viraemia and risk of virological failure in treated HIV-1-infected patientsR Teira, F Vidal, P Muñoz-Sánchez, et al.
Pageof 28